These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 23208833)

  • 21. Oseltamivir pharmacokinetics in morbid obesity (OPTIMO trial).
    Thorne-Humphrey LM; Goralski KB; Slayter KL; Hatchette TF; Johnston BL; McNeil SA;
    J Antimicrob Chemother; 2011 Sep; 66(9):2083-91. PubMed ID: 21700623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation.
    Lemaitre F; Luyt CE; Roullet-Renoleau F; Nieszkowska A; Zahr N; Fernandez C; Farinotti R; Combes A
    Intensive Care Med; 2010 Jul; 36(7):1273-4. PubMed ID: 20376428
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studies.
    Rayner CR; Bulik CC; Kamal MA; Reynolds DK; Toovey S; Hammel JP; Smith PF; Bhavnani SM; Van Wart SA; Ambrose PG; Forrest A
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3478-87. PubMed ID: 23669386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carboxylesterase 1 polymorphism impairs oseltamivir bioactivation in humans.
    Tarkiainen EK; Backman JT; Neuvonen M; Neuvonen PJ; Schwab M; Niemi M
    Clin Pharmacol Ther; 2012 Jul; 92(1):68-71. PubMed ID: 22588607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza A pandemic.
    Bentley ML; Hollistera AS; Hansenb AC; Smith JA; Cain JS
    Int J Clin Pharmacol Ther; 2014 Dec; 52(12):1105-11. PubMed ID: 25345428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome caused by novel 2009 influenza A (H1N1) virus].
    Zhan QY; Sun B; Tong ZH; Guo LM; Xu L; Zhu X; Jia XJ; Wang C
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3262-6. PubMed ID: 22333146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment of Severe Influenza B Virus Infection Requiring Organ Replacement Therapy.
    Karsch K; Chen X; Miera O; Peters B; Obermeier P; Francis RC; Amann V; Duwe S; Fraaij P; Heider A; de Zwart M; Berger F; Osterhaus A; Schweiger B; Rath B
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):155-164. PubMed ID: 26994602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SAPS 3 at dialysis commencement is predictive of hospital mortality in patients supported by extracorporeal membrane oxygenation and acute dialysis.
    Tsai CW; Lin YF; Wu VC; Chu TS; Chen YM; Hu FC; Wu KD; Ko WJ;
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1158-64. PubMed ID: 18757205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: a case series.
    Roncon-Albuquerque R; Basílio C; Figueiredo P; Silva S; Mergulhão P; Alves C; Veiga R; Castelo-Branco S; Paiva L; Santos L; Honrado T; Dias C; Oliveira T; Sarmento A; Mota AM; Paiva JA
    J Crit Care; 2012 Oct; 27(5):454-63. PubMed ID: 22386225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oseltamivir dosing in children undergoing hemodialysis.
    Schreuder MF; van der Flier M; Knops NB; Koster-Kamphuis L; Brüggemann RJ
    Clin Infect Dis; 2010 May; 50(10):1427-8. PubMed ID: 20397934
    [No Abstract]   [Full Text] [Related]  

  • 33. Oseltamivir oral suspension and capsules are bioequivalent for the active metabolite in healthy adult volunteers.
    Lennon S; Barrett J; Kirkpatrick C; Rayner C
    Int J Clin Pharmacol Ther; 2009 Aug; 47(8):539-48. PubMed ID: 19640363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of oseltamivir according to trimester of pregnancy.
    Greer LG; Leff RD; Rogers VL; Roberts SW; McCracken GH; Wendel GD; Sheffield JS
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S89-93. PubMed ID: 21492824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.
    Kamal MA; Lien KY; Robson R; Subramoney V; Clinch B; Rayner CR; Gibiansky L
    Antimicrob Agents Chemother; 2015 Nov; 59(11):6774-81. PubMed ID: 26282419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safe transport of critically ill adult patients on extracorporeal membrane oxygenation support to a regional extracorporeal membrane oxygenation center.
    Javidfar J; Brodie D; Takayama H; Mongero L; Zwischenberger J; Sonett J; Bacchetta M
    ASAIO J; 2011; 57(5):421-5. PubMed ID: 21869618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.
    Pai MP; Lodise TP
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5640-5. PubMed ID: 21930881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal membrane oxygenation for critically ill patients with influenza A (H1N1) 2009: a case series.
    Power CA; Van Heerden PV; Moxon D; Martindale G; Roberts B
    Crit Care Resusc; 2011 Mar; 13(1):38-43. PubMed ID: 21355828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation.
    Wu CC; Shen LJ; Hsu LF; Ko WJ; Wu FL
    J Formos Med Assoc; 2016 Jul; 115(7):560-70. PubMed ID: 26123638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure.
    Pettignano R; Fortenberry JD; Heard ML; Labuz MD; Kesser KC; Tanner AJ; Wagoner SF; Heggen J
    Pediatr Crit Care Med; 2003 Jul; 4(3):291-8. PubMed ID: 12831409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.